Form 144: Insider 10b5-1 Sales Listed

Company filing a Form 144 discloses proposed and recent insider sales of common stock and equity units.

Rhea-AI Filing Summary

Company filing a Form 144 discloses proposed and recent insider sales of common stock and equity units. The filing lists two 10b5-1 sales by Lisa Bodensteiner: 1,798 shares on 04/20/2026 for $147,199.02 and 334 shares on 03/18/2026 for $24,993.22. The filing also lists 306 Performance Stock Units and 306 Restricted Stock Units with an effective date of 05/17/2026.

Insights

Compliance Counsel

Form 144 documents proposed resale and recent 10b5-1 transactions by an insider.

The filing records two executed 10b5-1 sales by Lisa Bodensteiner with exact share counts and proceeds: 1,798 shares for $147,199.02 and 334 shares for $24,993.22. It also lists 306 PSUs and 306 RSUs dated 05/17/2026.

These entries are administrative disclosures that notify the market of proposed or completed sales under Rule 144 and 10b5-1 plans. Subsequent filings may report settlement details or additional transactions.

Key Figures

10b5-1 sale: 1,798 shares Proceeds: $147,199.02 10b5-1 sale: 334 shares +3 more

6 metrics

10b5-1 sale 1,798 shares sale date <date>04/20/2026</date>

Proceeds $147,199.02 proceeds from 1,798-share sale on <date>04/20/2026</date>

10b5-1 sale 334 shares sale date <date>03/18/2026</date>

Proceeds $24,993.22 proceeds from 334-share sale on <date>03/18/2026</date>

Performance Stock Units 306 units listed with date <date>05/17/2026</date>

Restricted Stock Units 306 units listed with date <date>05/17/2026</date>

Key Terms

10b5-1, Performance Stock Units, Restricted Stock Units

3 terms

10b5-1 regulatory

"10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive San Jose CA"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Performance Stock Units financial

"Common | 05/17/2026 | Performance Stock Units | Issuer"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

Restricted Stock Units financial

"Common | 05/17/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does SYNA's Form 144 disclose about recent insider sales?

The Form 144 lists two 10b5-1 sales by Lisa Bodensteiner: 1,798 shares on 04/20/2026 for $147,199.02 and 334 shares on 03/18/2026 for $24,993.22. It also notes intended sales of 306 PSUs and 306 RSUs dated 05/17/2026.

Who reported the sales on SYNA's Form 144 and under what plan?

The sales were reported for Lisa Bodensteiner and identified as 10b5-1 sales. The filing shows the transactions executed under prearranged 10b5-1 instructions with exact share counts and proceeds for the two trades listed.

How many Performance Stock Units and Restricted Stock Units are listed in the filing?

The filing lists 306 Performance Stock Units and 306 Restricted Stock Units with an indicated date of 05/17/2026. These unit counts appear under the securities to be sold section of the Form 144 excerpt.

Do the Form 144 entries state how proceeds will be used by the issuer?

The excerpt does not state any use of proceeds by the issuer. The Form 144 entries report proposed resale and recent insider sales with share counts and dollar amounts; they do not allocate proceeds or describe issuer receipt of funds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 04:35 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001213272
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SYNAPTICS INCORPORATED
SEC File Number	000-49602
Address of Issuer	1109 McKay Drive San Jose CALIFORNIA 95131
Phone	4089041100
Name of Person for Whose Account the Securities are To Be Sold	LISA BODENSTEINER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	612	72925.92	38637685	05/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/17/2026	Performance Stock Units	Issuer			306	05/17/2026	N/A
Common	05/17/2026	Restricted Stock Units	Issuer			306	05/17/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive San Jose CA 95131	Common	04/20/2026	1798	147199.02
10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive San Jose CA 95131	Common	03/18/2026	334	24993.22

144: Remarks and Signature

Remarks
Date of Notice	05/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Lisa Bodensteiner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)